跳至主要内容
临床试验/NCT06215222
NCT06215222招募中不适用

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

Stanford University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Collection of 50ul of intestinal fluid from >90% of microbiome sampling capsules

研究概览

简要总结

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females 18 years of age or older and 70 years of age or younger at the time of the first Screening Visit.
  • American Society of Anesthesiologists (ASA) Physical Status Classification System 1 or 2 (1-A normal healthy patient or 2-A patient with mild systemic disease)
  • For women of childbearing potential, negative urine pregnancy test within 7 days of Screening Visit. Willingness to use highly effective contraception during the entire study period (e.g.: implants, injectables, oral contraceptives, intra-uterine device or declared abstinence).
  • Subject is fluent in English and understands the study protocol and informed consent and is willing and able to comply with study requirements and sign the informed consent form.
  • Positive for at least one clinical symptoms consistent with SIBO and or IBS and or a Rome Diagnosis of functional GI disorder (Rome IV criteria)

排除标准

  • History of any of the following:
  • Prior gastric or esophageal surgery, including lap banding or bariatric surgery
  • Bowel obstruction
  • Gastric outlet obstruction
  • Diverticulitis
  • Inflammatory bowel disease
  • Ileostomy or colostomy
  • Gastric or esophageal cancer
  • Achalasia
  • Esophageal diverticulum
  • Active Dysphagia or Odynophagia
  • Active medication use for any gastrointestinal conditions
  • Pregnancy or planned pregnancy within 30 days from Screening Visit, or breast-feeding
  • Any form of active substance abuse or dependence (including drug or alcohol abuse), unstable medical or psychiatric disorder, or any chronic condition susceptible, in the opinion of the investigator, to interfere with the conduct of the study

结局指标

主要结局

Collection of 50ul of intestinal fluid from >90% of microbiome sampling capsules

时间窗: 1-4 years

Collection of 50ul of intestinal fluid from microbiome sampling capsules

次要结局

  • Isolation of liven bacteria from the intestinal fluid of >90% of microbiome sampling capsules(1-4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sean Spencer

Instructor

Stanford University

研究点 (1)

Loading locations...

相似试验